Haleon Taps Google Marketing Vet as US CMO to Drive Data-Centric Health Strategy
Event summary
- Richard Manso appointed US Chief Marketing Officer at Haleon, effective April 27, 2026.
- Manso will lead integrated marketing efforts to enhance consumer-centric health experiences.
- Focus areas include Medicare Advantage OTC, GLP-1 therapies, and emerging health platforms.
- Former Google executive brings expertise in data-driven and AI-enabled marketing solutions.
The big picture
Haleon's appointment of Manso reflects the broader industry shift towards data-driven, personalized marketing in consumer health. As individuals take more control over their well-being, companies like Haleon are repositioning marketing as a critical driver of trust and engagement. This move underscores the strategic importance of integrating technology and human insight to deliver relevant health experiences.
What we're watching
- Execution Risk
- Whether Manso can successfully integrate data, technology, and human insight to drive growth across Haleon's diverse product portfolio.
- Market Positioning
- How Haleon will differentiate itself in the increasingly competitive consumer health market by leveraging personalized marketing strategies.
- Strategic Alignment
- The pace at which Haleon can align its marketing capabilities with evolving consumer expectations for seamless, on-demand health experiences.